GBSN

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Verified Company Profile 8/25/2017
Contact Info
  • 420 E. South Temple
  • Suite 520
  • Salt Lake City, UT 84111

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001512138
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2008
Employees 98 a/o Aug 24, 2017
Company Officers/Contacts
Ryan P. Ashton CEO
Rob D. Jenison COO
Jeffrey A. Rona CFO
George Ulrich Director, Fin.
Company Directors
David R. Spafford Chairman
Ryan P. Ashton
Kirk K. Calhoun
Sam Chawla
Ron K. Labrum
Service Providers
Accounting/Auditing Firm
BDO USA, LLP
1801 Market Street
Suite 1700
Philadelphia, PA, 19103
United States
 
Securities Counsel
Mitchell Silberberg & Knupp LLP OTCQX Sponsor
12 East 49th Street
30th Floor
New York, NY, 10017
United States
 
Investor Relations Firm

Not Available
GBSN Security Details
Share Structure
Market Value1 $924,863 a/o Oct 19, 2017
Authorized Shares 1,500,000,000 a/o Aug 24, 2017
Outstanding Shares 9,248,631 a/o Aug 24, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 1,978,584 a/o Aug 24, 2017
Par Value Not Available
Shareholders
Shareholders of Record 474 a/o Aug 24, 2017
Short Selling Data
Short Interest 321,120 (103.92%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security